BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9501613)

  • 1. [Evaluation of diagnostic or screening procedures. Test validity, sensitivity, specificity, predictive values. Definition of and indications for mass screening].
    Rusch E
    Rev Prat; 1997 Dec; 47(19):2189-93. PubMed ID: 9501613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of diagnostic or detection procedures. Validity of tests, sensitivity, specificity, predictive values. Definition of and indications for mass screening].
    Chabot JM
    Rev Prat; 1991 Nov; 41(24):2529-32. PubMed ID: 1803469
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of diagnostic or screening procedures. Validity of tests, sensitivity, specificity, predictive values. Definition and indications for mass screening].
    Durand-Zaleski I; Bastuji-Garin S
    Rev Prat; 2000 May; 50(10):1155-8. PubMed ID: 10905104
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of diagnostic or screening procedures].
    Dab W
    Rev Prat; 1994 Apr; 44(7):989-91. PubMed ID: 7939314
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving the diagnosis of bipolar disorder: predictive value of screening tests.
    Phelps JR; Ghaemi SN
    J Affect Disord; 2006 Jun; 92(2-3):141-8. PubMed ID: 16529822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined one-tube osmotic fragility (OF) test and dichlorophenol-indolphenol (DCIP) test screening for hemoglobin disorders, an experience in 213 Thai pregnant women.
    Wiwanitkit V; Suwansaksri J; Paritpokee N
    Clin Lab; 2002; 48(9-10):525-8. PubMed ID: 12389713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing an instrument to screen for fibromyalgia syndrome in general population studies: the London Fibromyalgia Epidemiology Study Screening Questionnaire.
    White KP; Harth M; Speechley M; Ostbye T
    J Rheumatol; 1999 Apr; 26(4):880-4. PubMed ID: 10229410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia.
    Fucharoen G; Sanchaisuriya K; Sae-ung N; Dangwibul S; Fucharoen S
    Bull World Health Organ; 2004 May; 82(5):364-72. PubMed ID: 15298227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systematic reviews in practice. X. Searching, selecting and the methodological assessment of diagnostic evaluation research].
    Devillé WL; Bossuyt PM; de Vet HC; Bezemer PD; Bouter LM; Assendelft WJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2281-4. PubMed ID: 12497754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A screening test for depression in general practice. The COOP/WONCA chart].
    Pedersen JK; Damsbo N; Kragstrup J
    Ugeskr Laeger; 1999 Feb; 161(6):787-90. PubMed ID: 10028883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new screening tool for cervical dystonia.
    Saunders-Pullman R; Soto-Valencia J; Costan-Toth C; Shriberg J; Raymond D; Derby CA; Lipton RB; Bressman SB
    Neurology; 2005 Jun; 64(12):2046-9. PubMed ID: 15985569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new, rapid, qualitative, one-step PSA Test for prostate cancer screening: the PSA RapidScreen test.
    Miano R; Mele GO; Germani S; Bove P; Sansalone S; Pugliese PF; Micali F
    Prostate Cancer Prostatic Dis; 2005; 8(3):219-23. PubMed ID: 15897915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles of screening.
    Evans MI; Galen RS; Britt DW
    Semin Perinatol; 2005 Dec; 29(6):364-6. PubMed ID: 16533648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A risk score for selective screening for gestational diabetes mellitus.
    Phaloprakarn C; Tangjitgamol S; Manusirivithaya S
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):71-5. PubMed ID: 19446948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thorny nature of predictive validity studies on screening tests for developmental-behavioral problems.
    Marks K; Glascoe FP; Aylward GP; Shevell MI; Lipkin PH; Squires JK
    Pediatrics; 2008 Oct; 122(4):866-8. PubMed ID: 18829812
    [No Abstract]   [Full Text] [Related]  

  • 16. [Validation of the Spanish version of the attention deficit hyperactivity disorder adult screening scale (ASRS v. 1.1): a novel scoring strategy].
    Ramos-Quiroga JA; Daigre C; Valero S; Bosch R; Gómez-Barros N; Nogueira M; Palomar G; Roncero C; Casas M
    Rev Neurol; 2009 May 1-15; 48(9):449-52. PubMed ID: 19396760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Topicality of serologic screening of human immunodeficiency virus infections in adults].
    Dubrous P; Koeck JL; Coulot P; Blanchard de Vaucouleurs A
    Pathol Biol (Paris); 1998 Jan; 46(1):61-6. PubMed ID: 9769938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and litigation. Measures of validity need to be clear.
    Rooney CI; Rodrigues LC; Campbell OM
    BMJ; 2000 Sep; 321(7263):760; author reply 761. PubMed ID: 10999918
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and standardization of a new telephonic cognitive screening test: the Minnesota Cognitive Acuity Screen (MCAS).
    Knopman DS; Knudson D; Yoes ME; Weiss DJ
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Oct; 13(4):286-96. PubMed ID: 11186165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference values in medicine and validity of diagnostic test.
    Indrayan A; Satyanarayana L
    Indian Pediatr; 2000 Mar; 37(3):285-91. PubMed ID: 10750070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.